Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IGLV6-57 | P01721 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 3/20 | 0.39 |
| ▸ | MAOB | P27338 | 3/20 | 0.36 |
| ▸ | ACHE | P22303 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | CA4 | P22748 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6592532 | 0.92 | IGLV6-57 (0.51) | IGLV6-57RAB9AMAOBACHEMEN1 | |
| SCHEMBL6591554 | 0.92 | IGLV6-57 (0.39) | IGLV6-57RAB9AMAOBACHEMEN1 | |
| SCHEMBL27558085 | 0.87 | IGLV6-57 (0.35) | IGLV6-57RAB9AMAOBACHEMEN1 | |
| SCHEMBL6596608 | 0.85 | ACHE (0.42) | RAB9AMAOBACHEMEN1NPC1 | |
| SCHEMBL6594463 | 0.84 | RAB9A (0.41) | IGLV6-57RAB9AMAOBACHEMEN1 | |
| SCHEMBL6591398 | 0.84 | MAOB (0.54) | MAOBACHEMEN1NPC1KMT2A | |
| SCHEMBL6594080 | 0.82 | MAPT (0.47) | — | |
| SCHEMBL6591238 | 0.82 | KMT2A (0.42) | RAB9AMAOBMEN1KMT2A | |
| SCHEMBL6593971 | 0.81 | ACHE (0.49) | RAB9AMAOBACHEMEN1KMT2A | |
| SCHEMBL6596694 | 0.80 | ACHE (0.48) | RAB9AMAOBACHEMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1063235-B1 | BENZOFURYLPYRONE DERIVATIVES | TEIJIN LTD (JP) | 2004-05-12 | — | — | EP | disclosed |
| US-20030186976-A1 | Benzofurylpyrone derivatives | TEIJIN LIMITED, MICROBIAL CHEMISTRY RESEARCH FOUNDATION | 2003-10-02 | — | — | US | disclosed |
| EP-1063235-A1 | BENZOFURYLPYRONE DERIVATIVES | TEIJIN LIMITED (JP) | 2000-12-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030186976-A1 | Benzofurylpyrone derivatives | PLIN5, ACSL5, PLIN1 | IGLV6-57 4060/4885RAB9A 4399/4885MAOB 3367/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.